Skip to main content

February 2016

 

 

academics

 

Clinical research courses

Amgen announced that the randomized, double-blind, placebo-controlled Phase 3 Aranesp® (darbepoetin alfa) ARCADE trial met its primary endpoint of reducing the incidence of red blood cell transfusions in anemic patients with low and intermediate-1 risk Myelodysplastic Syndrome (MDS) at the end of the blinded 25-week study period. Aranesp also significantly improved erythroid response, a key measure of the formation of new red blood cells. Detailed results will be submitted to a future medical conference and for publication.

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding Merck's Supplemental New Drug Applications for ZETIA® and VYTORIN® for the reduction of the risk of cardiovascular events (cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, hospitalization for unstable angina, or need for revascularization) in patients with coronary heart disease.

Wenzel Spine, Inc., a pioneer medical device company focused on providing minimally invasive, stand-alone alternatives to traditional spinal fusion, announced today that it received clearance from the U.S. Food and Drug Administration (FDA) to market VariLift®-LX as an interbody fusion device for stand-alone use in the lumbar spine.

Submitted by admin on 18 February 2016

Hi Friends,

Fastest growing company suven health care releasing huge openings for Quality assurence and production (bulk, packing and formulations) for both freshers and experienced persons.

For experienced one relevent experience reuired in Quality assurence and freshers for production.

Please send your CV to rakigiri84@yahoo.com or else call to +91-7416181360

Regards,

Rakesh,

Shift Incharge

Suven health care

+91-7416181360

Walk in interview for Rehabilitation Therapist/Pharmacist/Asst. Librarian/Special Education Teacher/Vocational Instructor/Early Interventionist in NIMH

The National Institute for the Mentally Handicapped intends to empanel professionals/personnel as guest faculty as given below purely on session basis payment of honorarium to support its multifarious activities. The required qualification and experience and the honorarium that will be paid to different levels of Guest Faculty so engaged will be as under:

Post: Rehabilitation Therapist / Pharmacist / Asst.Librarian / Special Education Teacher / Vocational Instructor / Early Interventionist

Job for IP Information Analyst at Shilpa Medicare

Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. We initially started producing Trimethoprim IP/BP with in-house developed technology. During the first year of its operation, the Company had expanded the production facilities to manufacture Trimethoprim apart from selling on its own, for other reputed Companies like Eskayef Limited, Bombay Drugs and Pharmas Limited, Bombay Drug House Ltd., US Vitamins Ltd, Sandoz India Ltd etc. for their export commitments.

Post: IP Information Analyst

Job for Pharmacists (19 posts) in Department of Indian Systems of Medicine and Homeopathy, Puducherry

Applications are invited from the eligible Indian Citizens who are Natives /Residents of Union Territory of Puducherry for filling up the va cancies in the posts of Pharmacist (Ayurveda/Siddha/Homoeopathy/Unani) by direct recru itment. The details of posts to be filled by direct recruitment, Pay Band+Grade Pay of the post, Number of vacancies, age criteria, education and technical qualification, reservation under vertical basis, details of Employment Exchange registration and renewal made and methodology of recruitment and other conditions prescribed for submission of filled in applications are as follows :

Recruitment for Principal, Professor / Asst. Professor in CT Group of Institutions

CT Group of Institutions, A pioneer educational group in Jalandhar invites applications for the following post(s) for their Jalandhar Campuses & upcoming University in Ludhiana:

Post: Principal, Professor / Asst. Professor

Application are invited for DBT-Junior Research Fellowship Programme

Applications are invited from Indian nationals for the award of "DBT-Junior Research Fellowship" (DBT-JRF) for pursuing research in frontier areas of Biotechnology and Applied Biology. JRFs will be selected according to merit under two categories: Category I & II. Category I fellowship (Top 275 in number) are tenable in any University/Institute in India where the students can register for Ph.D. Category II students (100 in number) will be eligible to join any DBT sponsored project and avail fellowship from project, equivalent to NET/GATE qualifications as per DST Guidelines, subject to selection through institutional selection process. Registration for Ph.D will be decided by Institutional rules. Fellowship will be co-terminus with the duration of project and institutional rules will be applicable. There will be no binding on Pls of DBT sponsored projects to select JRF/SRF for their projects from category II list. Selection in Category II will not entitle student for any fellowship from DBT-JRF programme.